Join the Cardiovascular Conditions and Disorders group to help and get support from people like you.
Cardiovascular Conditions and Disorders News (Page 18)
TV Viewing Habits in Young Adulthood Tied to Cardiovascular Disease
THURSDAY, Aug. 29, 2024 – Greater television viewing in young adulthood is associated with incident cardiovascular disease (CVD) later in life, according to a study published online Aug. 22 in...
Recreational Drug Use Triples Odds for Repeat Heart Crises
WEDNESDAY, Aug. 28, 2024 – Recreational drug users are three times more likely to have repeated heart health emergencies than people who don’t use, a new study has found. About 11% of patients a...
Adding Greenery to Neighborhoods Brings Big Health Boost
WEDNESDAY, Aug. 28, 2024 – The trees and shrubs in your neighborhood could be giving you a big health boost, a new study finds. People have lower levels of inflammation in neighborhoods where the...
After Weighting, 3.6 Million Likely to Be Newly Eligible for Semaglutide
MONDAY, Aug. 26, 2024 – Increases in eligibility for semaglutide are discussed in a research letter published online Aug. 27 in the Annals of Internal Medicine. After the Semaglutide Effects on...
Cholesterol Could Be Link Between Menopause and Heart Disease
TUESDAY, Aug. 27, 2024 – During menopause, a woman’s blood cholesterol changes in a way that could harm her heart health, a new study warns. An increase in “bad” LDL cholesterol and a decrease in “go...
3.6 Million Americans Could Be Covered for Wegovy Under New Medicare Rules
TUESDAY, Aug. 27, 2024 – New Medicare rules could make 3.6 million Americans – or even more – eligible for treatment with the pricey weight-loss drug Wegovy, a new study finds. Under the new...
A Cardiologist Answers Your Questions on New Weight-Loss Meds, Ozempic and Zepbound
MONDAY, Feb. 12, 2024 – Weight loss drugs like Ozempic and Zepbound can lead to better heart health for people struggling with excess weight or diabetes, a University of Michigan cardiologist says....
A Cardiologist Answers Your Questions on New Weight-Loss Meds, Ozempic and Zepbound
MONDAY, Feb. 12, 2024 – Weight loss drugs like Ozempic and Zepbound can lead to better heart health for people struggling with excess weight or diabetes, a University of Michigan cardiologist says....
FDA Approves Gadavist (gadobutrol) Contrast Agent for Use in Cardiac MR in Adult Patients with Known or Suspected Coronary Artery Disease
WHIPPANY, N.J., July 15, 2019 /PRNewswire/ – Bayer announced today the U.S. Food and Drug Administration (FDA) has approved Gadavist (gadobutrol) injection for use in cardiac magnetic resonance (MR)...
FDA Approves Entresto (sacubitril/valsartan) for Heart Failure
July 7, 2015 – The U.S. Food and Drug Administration today approved Entresto (sacubitril/valsartan) tablets for the treatment of heart failure. The drug has been shown to reduce the rate of...
Further information
Related condition support groups
High Blood Pressure, Hypertension, High Cholesterol, Heart Failure, Congestive Heart Failure, Prevention of Thromboembolism in Atrial Fibrillation, Prevention of Cardiovascular Disease, Arrhythmia, Hypotension, Heart Disease